Compile Data Set for Download or QSAR
Found 226 with Last Name = 'viswanathan' and Initial = 'v'
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393561(US9969687, Compound 232)copy SMILEScopy InChI
Affinity DataKi:  3nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393572(US9969687, Compound 244)copy SMILEScopy InChI
Affinity DataKi:  3nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393520(US9969687, Compound 183)copy SMILEScopy InChI
Affinity DataKi:  3nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393600(US9969687, Compound 281)copy SMILEScopy InChI
Affinity DataKi:  4nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393559(US9969687, Compound 230)copy SMILEScopy InChI
Affinity DataKi:  6nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393557(US9969687, Compound 228)copy SMILEScopy InChI
Affinity DataKi:  6nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393553(US9969687, Compound 224)copy SMILEScopy InChI
Affinity DataKi:  6nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393530(US9969687, Compound 194)copy SMILEScopy InChI
Affinity DataKi:  6nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393569(US9969687, Compound 241)copy SMILEScopy InChI
Affinity DataKi:  7nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393566(US9969687, Compound 237)copy SMILEScopy InChI
Affinity DataKi:  9nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393534(US9969687, Compound 199)copy SMILEScopy InChI
Affinity DataKi:  10nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393606(US9969687, Compound 287)copy SMILEScopy InChI
Affinity DataKi:  10nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393585(US9969687, Compound 261)copy SMILEScopy InChI
Affinity DataKi:  11nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393603(US9969687, Compound 284)copy SMILEScopy InChI
Affinity DataKi:  12nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393528(US9969687, Compound 192)copy SMILEScopy InChI
Affinity DataKi:  12nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393552(US9969687, Compound 222)copy SMILEScopy InChI
Affinity DataKi:  12nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393516(US9969687, Compound 175)copy SMILEScopy InChI
Affinity DataKi:  12nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393567(US9969687, Compound 238)copy SMILEScopy InChI
Affinity DataKi:  13nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393517(US9969687, Compound 176)copy SMILEScopy InChI
Affinity DataKi:  13nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393605(US9969687, Compound 286)copy SMILEScopy InChI
Affinity DataKi:  14nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393609(US9969687, Compound 290)copy SMILEScopy InChI
Affinity DataKi:  14nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393610(US9969687, Compound 291)copy SMILEScopy InChI
Affinity DataKi:  15nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393611(US9969687, Compound 292)copy SMILEScopy InChI
Affinity DataKi:  16nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393541(US9969687, Compound 208)copy SMILEScopy InChI
Affinity DataKi:  16nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393597(US9969687, Compound 278)copy SMILEScopy InChI
Affinity DataKi:  17nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393536(US9969687, Compound 201)copy SMILEScopy InChI
Affinity DataKi:  17nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393598(US9969687, Compound 279)copy SMILEScopy InChI
Affinity DataKi:  17nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393580(US9969687, Compound 256)copy SMILEScopy InChI
Affinity DataKi:  18nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393588(US9969687, Compound 264)copy SMILEScopy InChI
Affinity DataKi:  18nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393602(US9969687, Compound 283)copy SMILEScopy InChI
Affinity DataKi:  20nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393529(US9969687, Compound 193)copy SMILEScopy InChI
Affinity DataKi:  21nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393581(US9969687, Compound 257)copy SMILEScopy InChI
Affinity DataKi:  21nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393562(US9969687, Compound 233)copy SMILEScopy InChI
Affinity DataKi:  21nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393584(US9969687, Compound 260)copy SMILEScopy InChI
Affinity DataKi:  22nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393522(US9969687, Compound 185)copy SMILEScopy InChI
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393509(US9969687, Compound 144)copy SMILEScopy InChI
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393568(US9969687, Compound 239)copy SMILEScopy InChI
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393607(US9969687, Compound 288)copy SMILEScopy InChI
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393545(US9969687, Compound 213)copy SMILEScopy InChI
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393601(US9969687, Compound 282)copy SMILEScopy InChI
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393555(US9969687, Compound 226)copy SMILEScopy InChI
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393521(US9969687, Compound 184)copy SMILEScopy InChI
Affinity DataKi:  24nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393587(US9969687, Compound 263)copy SMILEScopy InChI
Affinity DataKi:  25nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393589(US9969687, Compound 266)copy SMILEScopy InChI
Affinity DataKi:  25nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393549(US9969687, Compound 218)copy SMILEScopy InChI
Affinity DataKi:  26nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393494(US9969687, Compound 64)copy SMILEScopy InChI
Affinity DataKi:  27nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393593(US9969687, Compound 272)copy SMILEScopy InChI
Affinity DataKi:  29nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393550(US9969687, Compound 219)copy SMILEScopy InChI
Affinity DataKi:  30nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393539(US9969687, Compound 204)copy SMILEScopy InChI
Affinity DataKi:  30nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
TargetC-C chemokine receptor type 9(Homo sapiens (Human))
Pfizer

LigandPNGBDBM393556(US9969687, Compound 227)copy SMILEScopy InChI
Affinity DataKi:  32nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28W3GNHUS Patent
Displayed 1 to 50 (of 226 total ) | Next | Last >>
Jump to: